Eurovets is pleased to announce that we have entered into a distribution agreement with Dechra Pharmaceuticals.
The new contract will allow us to expand the exciting companion animal dermatological line-up to Companion and Equine Pharmaceutical products that will include endocrinology, gastrointestinal and ophthalmology.
Steven Wright (Managing Director - Eurovets Veterinary Suppliers) noted: “It was the projected next step for our long standing relationship - Dechra is a really exciting company, it is one of the fastest growing in vet pharma and is highly successful with proven expertise in developing market-leading products in the specialty veterinarian market. We are looking forward to partnering with them and giving them proper representation in the region, the growth prospects are exciting but also the opportunity to provide veterinarians with efficacious products to resolve many of the day-to-day challenges in their clinics.”
Dechra continues to push forward initiatives that add real value to Equine veterinary medicine. With some real interesting equine health products in development. In the past these programmes have resulted in some real success stories - such as bringing the first microencapsulated phenylbutazone to market. 35 years later, Equipalazone® remains a major product.